Feb 3, 2021 10:00am
BD's new diagnostic evaluates the status of a person’s immune system by gauging the amounts of specific types of white blood cells. (Getty Images)
BD has launched a new COVID-19 blood test in Europe that can help hospitals identify incoming patients that may be more likely to require intensive care with a ventilator and carry a higher risk of death from the disease.
The diagnostic evaluates the status of the person’s immune system by gauging the amounts of specific types of white blood cells.
The test kit “may help clinicians better determine an appropriate course of action for hospitalized COVID-19 patients, which is a top priority for this population,” said Puneet Sarin, worldwide president of BD Biosciences, and that the diagnostic can also help preserve medical resources.